Cargando…

Type I Collagen Synthesis Marker Procollagen I N-Terminal Peptide (PINP) in Prostate Cancer Patients Undergoing Intermittent Androgen Suppression

Intermittent androgen suppression (IAS) therapy for prostate cancer patients attempts to maintain the hormone dependence of the tumor cells by cycles alternating between androgen suppression (AS) and treatment cessation till a certain prostate-specific antigen (PSA) threshold is reached. Side effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamilton, Gerhard, Olszewski-Hamilton, Ulrike, Theyer, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759212/ https://www.ncbi.nlm.nih.gov/pubmed/24212969 http://dx.doi.org/10.3390/cancers3033601

Ejemplares similares

Measurement of bone turnover in prostate cancer patients receiving intermittent androgen suppression therapy
por: Theyer, Gerhard, et al.
Publicado: (2010)

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats
por: Veidal, Sanne Skovgård, et al.
Publicado: (2010)

Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy.
por: Theyer, G., et al.
Publicado: (1997)

Chinese Bone Turnover Marker Study: Reference Ranges for C-Terminal Telopeptide of Type I Collagen and Procollagen I N-Terminal Peptide by Age and Gender
por: Li, Mei, et al.
Publicado: (2014)

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
por: Saarto, T., et al.
Publicado: (1998)

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2021)

Giantin is required for intracellular N-terminal processing of type I procollagen
por: Stevenson, Nicola L., et al.
Publicado: (2021)

Correction: Giantin is required for intracellular N-terminal processing of type I procollagen
por: Stevenson, Nicola L., et al.
Publicado: (2021)

Quantitative Analysis of Serum Procollagen Type I C-Terminal Propeptide by Immunoassay on Microchip
por: Yatsushiro, Shouki, et al.
Publicado: (2011)

Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents
por: Choi, Ji Seon, et al.
Publicado: (2019)

Stepwise proteolytic activation of type I procollagen to collagen within the secretory pathway of tendon fibroblasts in situ
por: Canty-Laird, Elizabeth G., et al.
Publicado: (2011)

Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease
por: Su, Yiliang, et al.
Publicado: (2017)

The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts
por: Visigalli, Davide, et al.
Publicado: (2009)

Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification
por: Seo, Woo-Young, et al.
Publicado: (2017)

Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome
por: Ionin, Valery A., et al.
Publicado: (2020)

PINP as a biological response marker during teriparatide treatment for osteoporosis
por: Krege, J. H., et al.
Publicado: (2014)

Evaluation of Bone Metabolism in Critically Ill Patients Using CTx and PINP
por: Gavala, Alexandra, et al.
Publicado: (2016)

Parallel regulation of procollagen I and colligin, a collagen-binding protein and a member of the serine protease inhibitor family
Publicado: (1993)

Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors
por: Zhao, Hui, et al.
Publicado: (2011)

Diagnostic Value of Serum Procollagen III N-Terminal Peptide for Liver Fibrosis in Infantile Cholestasis
por: Wang, Yingcan, et al.
Publicado: (2020)

Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration
por: Cowan, David A., et al.
Publicado: (2021)

Dependence of Relative Expression of NTR1 and EGFR on Cell Density and Extracellular pH in Human Pancreatic Cancer Cell Lines
por: Olszewski-Hamilton, Ulrike, et al.
Publicado: (2011)

CD99/MIC2 Constitutes a Differentiation Antigen of a Human Osteoblast Cell Line
por: Hamilton, Gerhard, et al.
Publicado: (2011)

Serum Levels of Laminin, Type IV Collagen and Type III Procollagen Peptide as Markers for Detection of Metastasis
por: Yudoh, Kazuo, et al.
Publicado: (1994)

Immunohistochemical study of collagen types I and II and procollagen IIA in human cartilage repair tissue following autologous chondrocyte implantation
por: Roberts, S., et al.
Publicado: (2009)

AB37. The combination of I brachytherapy with intermittent androgen deprivation in treating locally advanced prostate cancer
por: Huang, Yi
Publicado: (2014)

COPII-coated membranes function as transport carriers of intracellular procollagen I
por: Gorur, Amita, et al.
Publicado: (2017)

Visualized procollagen Iα1 demonstrates the intracellular processing of propeptides
por: Tanaka, Toshiaki, et al.
Publicado: (2022)

Circulating Procollagen Type III N-Terminal Peptide and Physical Function in the Long Life Family Study
por: Santanasto, Adam, et al.
Publicado: (2020)

Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation
por: Zhao, Fei, et al.
Publicado: (2014)

Fibronectin matrix as a scaffold for procollagen proteinase binding and collagen processing
por: Saunders, Jared T., et al.
Publicado: (2019)

Immunohistochemical identification of type I procollagen in tumour cells of scirrhous adenocarcinoma of the stomach.
por: Niitsu, Y., et al.
Publicado: (1988)

Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells
Publicado: (1994)

PINP: A New Method of Tagging Neuronal Populations for Identification during In Vivo Electrophysiological Recording
por: Lima, Susana Q., et al.
Publicado: (2009)

Value of Procollagen Type I Aminoterminal Propeptide in Women with Breast Cancer with regard to Metastases
por: Clouth, A., et al.
Publicado: (2011)

Intermittent chemotherapy in metastatic androgen-independent prostate cancer
por: Beer, T M, et al.
Publicado: (2003)

Data comparing the kinetics of procollagen type I processing by bone morphogenetic protein 1 (BMP-1) with and without procollagen C-proteinase enhancer 1 (PCPE-1)
por: Moschcovich, Laura, et al.
Publicado: (2016)

Intracellular interaction of collagen-specific stress protein HSP47 with newly synthesized procollagen
Publicado: (1996)

Structural Basis for the Acceleration of Procollagen Processing by Procollagen C-Proteinase Enhancer-1
por: Pulido, David, et al.
Publicado: (2018)

TANGO1 and SEC12 are copackaged with procollagen I to facilitate the generation of large COPII carriers
por: Yuan, Lin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j65lcq3gjtthpsvoo4j6hp0o9m